EVO

Evotec SE is a life science company specializing in drug discovery and development. It integrates advanced technologies and AI-driven innovation to accelerate the drug development process, offering services that include small molecules, biologics, and cell therapies. The company partners with pharmaceutical companies, biotech firms, and academic institutions, providing standalone services as well as fully integrated R&D programs. Evotec operates globally, with a focus on therapeutic areas such as oncology, cardiovascular and metabolic diseases, neurology, and immunology.